U.S. federal trademark · Serial No. 87287749 · Reg. No. 6315836
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, none of the foregoing related chemical research, research services in connection with physics and engineering research, or to photovoltaic installations
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.